Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
AD047
- Development stage
- Unknown
- Lead developer
- Apnimed
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
**AD047** is an investigational Apnimed small-molecule drug candidate evaluated in a completed Phase 1/2 Australian study in adults with obstructive sleep apnea. Publicly available trial-linked information confirms the candidate name, sponsor, indication, and study phase, but does not disclose AD047's chemical identity, pharmacological target, mechanism of action, formulation, dose, or route of administration. It should not be conflated with **AD47**, a separately reported vitamin D receptor modulator from an unrelated academic publication. ([synapse.patsnap.com](https://synapse.patsnap.com/drug/4d1ab0e7cf78424f9f4a459b7f5bdfb9))
Beyond the preview
Go deeper on AD047.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AD047.